Use of theophylline to control hematocrit in respiratory polycythemia.
作者信息
Souweine B, Serre A F, Fialip J, Jimenez C, Philippe P
出版信息
Ann Pharmacother. 1993 Jul-Aug;27(7-8):978. doi: 10.1177/106002809302700730.
PMID:8364287
Abstract
摘要
相似文献
1
Use of theophylline to control hematocrit in respiratory polycythemia.
Ann Pharmacother. 1993 Jul-Aug;27(7-8):978. doi: 10.1177/106002809302700730.
2
Effect of theophylline on erythrocytosis in chronic obstructive pulmonary disease.茶碱对慢性阻塞性肺疾病红细胞增多症的影响。
Arch Intern Med. 1997 Jul 14;157(13):1474-8.
3
Polycythemia in chronic obstructive pulmonary disease. A study of serum and urine erythropoietin and medullary erythroid progenitors.
Chest. 1987 Nov;92(5):867-70. doi: 10.1378/chest.92.5.867.
4
High haematocrit in haemodialysis patients can be controlled by theophylline administration.血液透析患者的高血细胞比容可通过给予茶碱来控制。
Nephrol Dial Transplant. 1994;9(2):189-91.
5
Theophylline modulates erythrocytosis after renal transplantation.茶碱可调节肾移植后的红细胞增多症。
Nephron. 1995;70(1):25-7. doi: 10.1159/000188539.
6
Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis.
Ann Intern Med. 2001 Mar 6;134(5):426-7. doi: 10.7326/0003-4819-134-5-200103060-00022.
7
[Treatment of respiratory insufficiency in chronic nonspecific lung diseases].[慢性非特异性肺部疾病呼吸功能不全的治疗]
Klin Med (Mosk). 1995;73(4):24-7.
8
Optimal hematocrit and blood viscosity in secondary polycythemia as determined from cerebral blood flow.根据脑血流量确定的继发性红细胞增多症中的最佳血细胞比容和血液粘度。
Clin Invest Med. 1981;4(2):117-21.
9
Association between activation of the renin-angiotensin system and secondary erythrocytosis in patients with chronic obstructive pulmonary disease.
Am J Med. 1999 Feb;106(2):158-64. doi: 10.1016/s0002-9343(98)00390-8.
10
Serum immunoreactive erythropoietin in hypoxic lung disease with and without polycythaemia.
Clin Sci (Lond). 1985 Oct;69(4):413-22. doi: 10.1042/cs0690413.
Zotero 插件